Table 2

Interaction (G×E) and correlation (rGE) between genetic variants of genes of monoamine neurotransmission and measures of early development (G×EDev, rGEDev)* and of social environment (G×ESoc, rGSoc) and gender (G×Sex) on current depressive symptoms (Hopkins Symptom Check List score), and genetic association with Hopkins Symptom Check List score in the complete study sample from the NFBC 1966 (All)

GeneGene nameChromosomeSNPPosition/bpMinor alleleMAFP (G×EDev)P (G×ESoc)P (G×sex)P (All)P (rGEDev)P (rGSoc)
SLC6A4Serotonin transporter17rs190645125539605G0.440.6080.3630.7840.2680.7470.035
rs379480825555919A0.410.3650.2630.7990.3200.4020.064
rs14070025567515A0.090.1330.4600.037§§0.8760.2090.614
rs206671325575791A0.460.2530.4990.5050.5500.7780.092
rs807166725576899A0.150.4730.6820.1220.6060.9610.827
TPH2Tryptophan hydroxylase 212rs413134870610746G0.120.8440.9370.4000.4970.7050.241
rs212957570626340A0.220.7870.6820.4320.4230.1730.298
rs138649670637057G0.160.9830.4040.2930.7920.8370.226
rs217136370646531A0.430.7620.9830.016§§0.8140.6920.940
rs1050664570671767A0.230.9960.7560.1020.7890.8880.721
rs138649770678557C0.170.8160.1310.4520.7970.6400.172
rs148727670691326A0.210.8880.0880.8380.9080.5910.219
rs932520270693744A0.480.8050.0740.4880.4730.9130.675
rs148727570696559C0.370.9720.0540.6250.049***0.8610.638
rs138648370698761A0.470.5740.0900.3260.4370.2940.625
rs187282470716581A0.350.6520.1210.2110.4940.7720.331
COMTCatechol-O-methyltransferase22rs651859118304021G0.160.6880.2550.9190.3030.1500.385
rs73786618310109G0.180.028§0.8530.024§§0.7550.6230.489
rs154432518311668G0.480.3180.3760.1920.8220.9990.931
rs17467518314051A0.290.4650.2780.5800.9580.7240.532
rs599388318317638C0.360.2300.4950.025§§0.9200.3630.219
rs223939318330428G0.310.0050.7650.2560.9300.8380.459
rs468018331271G0.450.020**0.9560.5010.3460.4120.498
rs464631618332132A0.180.2050.1650.9330.026†††0.5210.392
rs16577418332561A0.250.0810.5160.0890.2150.5380.239
rs16581518339473G0.200.5370.3090.4310.2810.3380.158
rs88719918341955A0.200.5440.3250.4010.3060.3140.168
rs223939518342203C0.020.1440.6550.1530.3900.2240.664
MAOAMonoamine oxidase AXrs90952543438146G0.450.5590.8710.5540.1650.2550.932
rs1284326843458610A0.400.2710.8370.2660.1030.0520.932
rs661084543472954G0.410.2320.7950.2630.1700.0600.524
rs302740943491977C0.020.7480.9280.9500.1940.7030.068
rs660925743497652G0.500.8480.3200.4700.0770.0750.898
rs302741543499385G0.180.2180.5500.9050.6130.1050.408
DRD1Dopamine receptor D15rs265973174793305G0.500.5290.6140.5490.8880.0470.831
rs265974174793846G0.350.3910.6120.9120.6590.0660.859
rs265976174795026A0.230.5780.7070.9150.8260.0770.933
rs5326174802802A0.190.6150.8860.8520.5880.2730.197
DRD2Dopamine receptor D211rs1800497112776038A0.170.0790.8250.6910.4670.9210.264
rs2242592112784640G0.370.7570.4660.2830.7360.1430.393
rs1076563112801119C0.500.0530.8130.8970.6620.2340.856
rs2471857112803549A0.170.5180.4940.8230.9010.8840.126
rs4620755112814829A0.220.3830.9970.9510.1760.0650.992
rs7125415112815891A0.190.0840.3890.7890.2310.1630.947
rs4648318112818599G0.340.7110.8850.6310.6840.2140.466
rs4274224112824662G0.240.0670.7770.017¶¶0.022‡‡‡0.5360.766
rs4581480112829684G0.070.1840.5210.2100.009§§§0.0820.760
rs7131056112834984C0.490.5640.7950.4130.9640.6220.138
rs4938019112846601G0.230.0690.6510.6430.5840.3200.059
rs12364283112852165G0.080.2800.5040.4410.8610.6330.804
rs10891556112857971A0.240.0760.5190.6380.5890.3800.052
rs6589377112860946G0.170.2860.6170.0610.5520.5020.915
DRD3Dopamine receptor D33rs2087017115324703G0.430.9370.9210.6060.7430.8350.828
rs2134655115340891A0.280.4540.5540.1290.5070.2090.330
rs963468115345577A0.380.8090.7770.9020.6080.6090.580
rs3773678115352768A0.060.7800.8550.4870.7700.9720.556
rs2630351115357749A0.030.9540.1440.1680.9990.8110.211
rs167771115358965G0.180.8620.6380.4060.5140.4160.966
rs167770115362252G0.310.2600.9110.2980.6940.5930.982
rs226082115363703G0.310.2610.9110.3010.6900.5940.983
rs324029115364313A0.310.2590.9130.2960.7220.5930.964
rs10934256115368342A0.170.2290.8980.4780.2460.1470.669
rs1486009115371222G0.120.7210.6670.7450.5710.3870.600
rs6280115373505G0.330.1590.4850.1410.6670.3860.880
rs9825563115382910G0.230.045††0.9020.2110.2150.0280.927
DRD4Dopamine receptor D411rs3758653626399G0.230.3000.7520.2490.9800.3220.905
rs11246226631191A0.490.7490.7480.1660.9250.9080.097
DRD5Dopamine receptor D54rs18789439375986A0.210.5860.6860.4820.3860.9880.605
rs131065399406801G0.390.7350.0620.0670.044¶¶¶0.5320.384
  • The analyses were performed using PLINK's linear and logistic regression models and interaction analysis. Empirical p values based on max(T) permutation are reported, with p values <0.05 shown in bold.

  • * Defined by the presence of two out of three possible indicators for high early developmental risk: low birth weight, late motor development and late development of speech.

  • Defined by the presence of two out of five possible indicators for high social risk environment: unwanted pregnancy, low socio-economic status, single parenthood, low level of education of mother and low activity for information retrieval by the mother.

  • Minor allele frequency.

  • § p=0.0364 (β=0.0414).

  • p=0.008 (β=0.0440).

  • ** p=0.042 (β=0.0320).

  • †† p=0.022 (β=–0.0396) in individuals at high risk group.

  • §§ p>0.05 in both genders.

  • ¶¶ p=0.0006 (β=0.023) in males.

  • *** β=0.008.

  • ††† β=0.012.

  • ‡‡‡ β=0.011.

  • §§§ β=0.022.

  • ¶¶¶ β=−0.